Conservative. Idaho. Software engineer. Historian. Trying to prevent Idiocracy from becoming a documentary.
Email complaints/requests about copyright infringement to clayton @ claytoncramer.com. Reminder: the last copyright troll that bothered me went bankrupt.
Wednesday, September 29, 2021
Vaxracism!
Saturday, September 25, 2021
The Good News
Friday, September 10, 2021
Why Are So Many Americans Vaccine-Hesitant?
Sunday, September 5, 2021
Do You Wonder Why People Are Reluctant to Get Vaccinated?
Thursday, July 29, 2021
Fear Addiction
Requiring Masking
"Nearly all COVID-19 deaths in the U.S. now are in people who weren’t vaccinated, a staggering demonstration of how effective the shots have been and an indication that deaths per day — now down to under 300 — could be practically zero if everyone eligible got the vaccine."
Tuesday, July 27, 2021
Reading CNN Stories Like This
- If you are fully vaccinated, you can participate in many of the activities that you did before the pandemic.
- To maximize protection from the Delta variant and prevent possibly spreading it to others, wear a mask indoors in public if you are in an area of substantial or high transmission.
Saturday, May 29, 2021
Ivermectin
Saturday, May 22, 2021
Masking
Wednesday, April 28, 2021
New York Times Article About Why Europe is Lagging Behind the U.S. and U.K. in COVID19 Vaccinations
Vaccine salvation remains, for now, still tantalizingly out of reach. Only about 10 percent of Europeans have received a first dose, compared with 23 percent in the United States and 39 percent in Britain.
There is no single culprit. Rather, a cascade of small decisions have led to increasingly long delays. The bloc was comparatively slow to negotiate contracts with drugmakers. Its regulators were cautious and deliberative in approving some vaccines. Europe also bet on vaccines that did not pan out or, significantly, had supply disruptions. And national governments snarled local efforts in red tape.
The United States basically went into business with the drugmakers, spending much more heavily to accelerate vaccine development, testing and production.
“They assumed that simply contracting to acquire doses would be enough,” recalled Dr. Slaoui, whom President Donald J. Trump hired to speed the vaccine development. “In fact what was very important was to be a full, active partner in the development and the manufacturing of the vaccine. And to do so very early.”
The European Union trailed the United States and Britain from the start.
Washington had already spent billions on clinical trials and manufacturing by the time Europe decided to pool its resources and negotiate as a bloc. In mid-June, the European Commission, the bloc’s executive branch, announced a joint vaccine purchase with a $3.2 billion pot.
In Washington, Operation Warp Speed, the Trump administration’s vaccine program, had a $10 billion budget. European officials say it’s unfair to compare the two figures because neither amount is a complete picture of all the money spent on vaccines. But there is no dispute that in Washington, officials had decided that money was no object if vaccines could avert the economic cost of a lockdown. Europe, on the other hand, was on a tight budget, so its negotiators chased cheaper doses.